Poliosis Is Associated with Response to Checkpoint-Inhibitor Therapy: A Case Report of Two Patients with Multifocal Metastatic Melanoma
The advent of immune-checkpoint inhibitors (ICIs) led to significant improvements in the treatment of patients with advanced melanoma and resulted in durable tumor responses in a considerable number of advanced melanoma patients. Next to the immune-mediated anti-neoplastic effects, ICIs may cause va...
Main Authors: | Maximilian Haist, Henner Stege, Verena Maikranz, Maria Halley Blanco, Stephan Grabbe, Carmen Loquai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Immuno |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-5601/2/2/20 |
Similar Items
-
The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma—A Retrospective, Real-World Cohort Study
by: Maximilian Haist, et al.
Published: (2022-04-01) -
Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors—A Retrospective, Real-World Cohort Study
by: Maximilian Haist, et al.
Published: (2021-10-01) -
Paediatric Poliosis as the Presenting Feature of Scalp Vitiligo: A Retrospective Case Series
by: Ji Yeon Hong, et al.
Published: (2022-10-01) -
Giant Congenital Melanocytic Nevi and Poliosis in a 3-Day-Old Boy: Is it Just a Coincidence?
by: Ahu Yorulmaz, et al.
Published: (2022-02-01) -
Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
by: Markus V. Heppt, et al.
Published: (2019-11-01)